<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04884698</url>
  </required_header>
  <id_info>
    <org_study_id>Stimit swiss I</org_study_id>
    <nct_id>NCT04884698</nct_id>
  </id_info>
  <brief_title>&quot;Electromagnetical Stimulation of Phrenic Nerve to Generate Contraction of the Diaphragm&quot;</brief_title>
  <official_title>&quot;Electromagnetical Stimulation of the Phrenic Nerve to Generate Contraction of the Diaphragm in Healthy Subjects and Anaesthetized and Intubated Patients - a Feasibility Study&quot;</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stimit AG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stimit AG</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The scientific study is intended to show that external non-invasive electromagnetic&#xD;
      stimulation can be used to safely and effectively stimulate the phrenic nerve in awake&#xD;
      healthy subjects as well as in ventilated, anesthetized patients and that the stimulation can&#xD;
      generate a diaphragmatic contraction that generates significant breath volume - a Controlled&#xD;
      Own Breath (COB).&#xD;
&#xD;
      Also of interest is the reproducibility of the generated diaphragmatic movements and the&#xD;
      reliability of different feedback signals for detecting the generated diaphragmatic&#xD;
      contraction. This applies to inspiration and expiration detection for subsequent&#xD;
      synchronization mechanisms of the magnetic stimulator for patient-initiated breathing as well&#xD;
      as to contraction intensity. Further, the characterization of the position finding process is&#xD;
      of great importance, so that technical developments can further simplify the process of coil&#xD;
      positioning in the future. The possible occurrence of discomfort and pain sensation will also&#xD;
      be investigated in awake healthy volunteers. Different stimulation protocols will be used.&#xD;
&#xD;
      Finally, it will be investigated whether an adjusted coil position still triggers&#xD;
      reproducible diaphragmatic contractions after removal and repositioning in the same&#xD;
      configuration. The knowledge gained will be used to further develop the technique and to&#xD;
      prepare a study in critically ill, ventilated patients where the diaphragmatic muscle is to&#xD;
      be treated preventively by stimulating the phrenic nerve, in order to prevent atrophy of the&#xD;
      muscle.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 25, 2021</start_date>
  <completion_date type="Anticipated">February 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Open-label, sponsor-initiated feasibility study. 2 groups of patients treated - healthy subjects and elective surgery patient</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in airway pressure / endpoint Group 1:</measure>
    <time_frame>During stimulation</time_frame>
    <description>The primary outcome / endpoint is the change in airway pressure at the mouth during stimulation as seen with or without the use of the ventilator</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Discomfort / pain during stimulation measured by Visual Analogue Scale / endpoint Group 1:</measure>
    <time_frame>During stimulation</time_frame>
    <description>The primary outcome / endpoint is the level of discomfort / pain during stimulation, measured by Visual Analogue Scale(0-100, with 100 being worst pain / discomfort)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in airway pressure / endpoint Group 2:</measure>
    <time_frame>During stimulation</time_frame>
    <description>The primary outcome / endpoint is the change in airway pressure during stimulation as seen with or without the use of the ventilator during stimulation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Diaphragmatic contraction</measure>
    <time_frame>During stimulation</time_frame>
    <description>Diaphragmatic contraction at 20 percent / 30 percent / 40 percent stimulation intensity at the optimal stimulation site, at 25 Hz and 2s stimulation time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Feedback signals</measure>
    <time_frame>During stimulation</time_frame>
    <description>Change of the maximum value of the feedback signals in percent of the maximum depending on the coil position (in 0.5 cm steps; at least 3 steps in each direction)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time stimulation start to end</measure>
    <time_frame>During stimulation</time_frame>
    <description>Time (mean value &amp; standard deviation) between stimulation start and stimulation end (trigger signal start and end) until the feedback signals from:&#xD;
the abdominal belt,&#xD;
the Diaphragm Thickening Fraction ((TFdi) according to standard procedure, measured via ultrasound during stimulation), and&#xD;
the Diaphragm Excursion Signal &quot;respons&quot; (measured by ultrasound during stimulation)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation stimulation intensity and diaphragm contraction</measure>
    <time_frame>During stimulation</time_frame>
    <description>Correlation between stimulation intensity (power output in percent) and diaphragm contraction, measured by tidal volume, at the optimal coil position at given frequency (25 Hz) and given stimulation duration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Optimal stimulation site - distance</measure>
    <time_frame>During stimulation</time_frame>
    <description>Distance from anatomical landmark (a) to optimal stimulation site (b) and phrenic nerve (c) using ultrasound and between b and c</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Optimal stimulation site - time</measure>
    <time_frame>During stimulation</time_frame>
    <description>Time from the start of coil positioning to finding a coil positioning which produces the maximum diaphragmatic contraction at a given stimulation intensity and frequency of 25 Hz</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tidal volumes</measure>
    <time_frame>During stimulation</time_frame>
    <description>The mean and standard deviation of generated tidal volumes for ten stimulations performed without the subject being ventilated</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Skin reactions / musle activation</measure>
    <time_frame>During stimulation</time_frame>
    <description>For Group 1: evaluation of stimulation-induced local skin reactions or muscle activation leading to paresthesia in the dental area</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety outcome</measure>
    <time_frame>During stimulation and postoperatively, usually within 2-3 hours</time_frame>
    <description>The safety outcome/ endpoint is the occurrence of the following events during stimulation:&#xD;
Device related Adverse Events&#xD;
Device related Serious Adverse Events</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Healthy Subjects</condition>
  <condition>Elective Surgical Procedure</condition>
  <arm_group>
    <arm_group_label>Phrenic nerve stimulation with Stimit Activator</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Stimit Activator</intervention_name>
    <description>The Stimit Activator Device is composed of three components.&#xD;
A magnetic stimulator generating current pulses&#xD;
A novel Stimit coil design optimized for phrenic nerve stimulation&#xD;
A coil positioning device for quick, easy and reproducible coil positioning</description>
    <arm_group_label>Phrenic nerve stimulation with Stimit Activator</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Persons aged &gt; 18 years&#xD;
&#xD;
          -  Applicable for Group 2: planned for elective surgery&#xD;
&#xD;
          -  No relevant pre-existing conditions - corresponding to American Society of&#xD;
             Anesthesiologists (ASA) level of I-II.&#xD;
&#xD;
          -  Written informed consent by the patient for participation in the study given&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  chronic lung diseases (bronchial asthma, COPD)&#xD;
&#xD;
          -  known diaphragmatic weakness&#xD;
&#xD;
          -  known neurological conditions with motor muscle weakness&#xD;
&#xD;
          -  known paralysis of the phrenic nerve&#xD;
&#xD;
          -  conditions that limit the mobility of the diaphragm (high intra-abdominal pressure,&#xD;
             ascites, BMI &gt;30)&#xD;
&#xD;
          -  not able to read and understand the national language German&#xD;
&#xD;
          -  skin lesions, infections or strictures in the neck area&#xD;
&#xD;
          -  persons with Implanted cardiac support systems (pacemaker, implanted defibrillator)&#xD;
&#xD;
          -  persons with implanted medical pumps&#xD;
&#xD;
          -  pregnant women&#xD;
&#xD;
          -  persons deprived of liberty by administrative or judicial decision or under legal&#xD;
             guardianship.&#xD;
&#xD;
          -  Participation in another clinical trial&#xD;
&#xD;
          -  Applicable for group 2 (intubated and mechanically ventilated) patients: Exclusion&#xD;
             criteria at the time of stimulation:&#xD;
&#xD;
               -  Unstable patient after induction of anesthesia and intubation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Baumberger, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Swiss Paraplegic Center Nottwil</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Harald Genger</last_name>
    <phone>+491757245185</phone>
    <email>harald.genger@stimit.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>XinLin Alt-Epping</last_name>
    <phone>+41791748951</phone>
    <email>xinlin.altepping@stimit.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Swiss Paraplegic centre</name>
      <address>
        <city>Nottwil</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gaby MÃ¼ller, MD</last_name>
    </contact>
    <investigator>
      <last_name>Michael Baumberger, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>April 30, 2021</study_first_submitted>
  <study_first_submitted_qc>May 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 13, 2021</study_first_posted>
  <last_update_submitted>September 6, 2021</last_update_submitted>
  <last_update_submitted_qc>September 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

